Comments to FDA: Probiotics Labeling

Share page:
Docket Number:
FDA-2011-D-0376

Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).

Related Posts

CHPA Comments on News of Dismissals & Layoffs at FDA

CHPA Honors & Remembers Michael McGuffin

CHPA Responds to Senate Confirming RFK Jr. to Lead HHS